BackPharmacolog i Uppsala AB (publ) Overview

Pharmacolog i Uppsala AB (publ) Profit Margin

Latest profit margin for Pharmacolog i Uppsala AB (publ): -181.61% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

153.53%
↑ 273.28% YoY

As of Mar 2024

Annual Profit Margin (TTM)

-181.61%
↓ 20.90% YoY

Trailing 12 months ending Mar 2024

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Pharmacolog i Uppsala AB (publ) (PHLOG-B.ST) FAQ

As of the most recent data (March 2024), PHLOG-B.ST shows a profit margin of -181.61%. That compares with -150.22% in the prior-year period — down 20.9% year over year. That is below the sector sector average of 13.23%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PHLOG-B.ST's profit margin is now -181.61% (was -150.22%) — a 20.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pharmacolog i Uppsala AB (publ) is outperforming or lagging.

The its sector sector average profit margin is about 13.23%. Pharmacolog i Uppsala AB (publ) is at -181.61%, which is lower that average. That is roughly 1473.1% below the sector mean. Use the comparison chart on this page to see how PHLOG-B.ST stacks up against individual peers as well.

That compares with -150.22% in the prior-year period — down 20.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Pharmacolog i Uppsala AB (publ) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Pharmacolog i Uppsala AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -181.61%) with ownership activity and broader fundamentals.